S. Micic

Beta blocker rebound phenomenon is important, but we do not know its definition, incidence or optimal prevention strategies

D. Lovic, M. Tomasevic, G. Koraćević, 2020, Hypertension Research.

High likelihood for atrial fibrillation in Cushing's syndrome.

M. Zdravkovic, G. Koraćević, T. Kostić, 2020, European review for medical and pharmacological sciences.

Cushing's Syndrome should be Cited as a Disease with High Cardiovascular Risk in Relevant Guidelines.

D. Lovic, G. Koraćević, T. Kostić, 2018, Current vascular pharmacology.

A Need for Improvement in the Definition of Resistant Arterial Hypertension

M. Zdravković, G. Koraćević, M. Stojanović, 2023, Medicina.

Compelling indications should be listed for individual beta-blockers (due to diversity), not for the whole class.

D. Lovic, G. Koraćević, A. Stojković, 2020, Current vascular pharmacology.